BioVie, Inc. (BIVI) Dividend History

BioVie, Inc. is a biotech company focused on developing innovative therapies for neurodegenerative and liver diseases. The company is known for its research into drug candidates aimed at addressing unmet medical needs, particularly in conditions such as hepatic encephalopathy. BioVie's approach involves leveraging novel mechanisms and proprietary formulations to create impactful treatments.

680 W Nye Lane, Carson City, NV, 89703
Phone: 775-888-3162
Website: https://www.bioviepharma.com

Dividend History

BioVie, Inc. currently does not pay dividends

Company News

  • The Alzheimer's disease market is expected to grow significantly between 2025-2034, driven by emerging therapies targeting disease mechanisms and improved diagnostic capabilities, with the US market representing approximately 50% of the total market size.

    GlobeNewswire Inc.
    Featured Companies: ANVS LLY
  • BioVie Inc. (BIVI) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

    Zacks Investment Research
  • U.S. stocks traded lower toward the end of trading, with the S&P 500 edging lower on Monday. The Dow traded down 0.20% to 39,007.30 while the NASDAQ fell 0.18% to 16,245.77. The S&P 500 also fell, dropping, 0.01% to 5,137.05. Check This Out: Top 4 Tech Stocks That May Implode This Month   Leading and Lagging Sectors   Utilities shares rose by 0.9% on Monday. In trading on Monday, communication services shares fell by 1.6%.   Top Headline   Super Micro Computer, Inc. (NASDAQ: SMCI) will join the S&P 500 Index, effective March 18, S&P Dow Jones Indices, a division of S&P Global, said in a release. Deckers Outdoor Corporation (NASDAQ: DECK) will replace Zions Bancorporation (NASDAQ: ZION) in the S&P 500.   Equities Trading UP   Cardiff Oncology, Inc. (NASDAQ: CRDF) shares shot up 16% to $3.3862 after the company reported better-than-expected fourth-quarter financial results, provided a clinical update on the Phase 2 randomized second-line ...

    Benzinga
    Featured Companies: BCDA CRDF DECK SMCI ZION
  • Here's 3 habits for penny stocks traders to use in 2024 The post Top Habits Penny Stocks Traders Need to Follow appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: ADIL JAGX
  • Misconduct issues were identified in several BioVie trial sites, leading to exclusion of majority of enrolled patients and a severely underpowered study. Read more here.

    Seeking Alpha
Page data last updated 07/23/2025 13:02:44 UTC